Industry trends in antibody partnering – 2007 to 2013

Email address:

First name:

Last name:

Job title:

Company name:

Country:

I work for

Please specify your industry *

please check before submitting

Mobile number:

What is your role?

Unfortunately the document is not available at this current time, however if you leave your details we'll get it to you as soon as we can.

Please fill in all the information requested. It is very important you enter this information correctly so we can contact you with the document.

Privacy statement »

Manage your email preferences »

Remember my details Information

Remember my details

We place a 'cookie' on your computer so next time you visit us you don't need to fill in all these details

close »

Blogged on behalf of Current Partnering, Wildwood Ventures

Antibodies are the subject of numerous partnering deals every year, here we provide a review of recent deal making activity. An antibody, also known as an immunoglobulin, is a large Y-shaped protein produced by B-cells that is used by the immune system to identify and neutralize foreign objects such as bacteria and viruses.

According to the Current Agreements life science deals and alliance database, around 1,000 antibody partnering deals were announced since 2007.

Download this article to find out more about antibody dealmaking trends between 2007 and 2013 >

Industry trends in antibody partnering – 2007 to 2013

information we require

please check before submitting